Compare ZS & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZS | DXCM |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0B | 25.9B |
| IPO Year | 2018 | 2005 |
| Metric | ZS | DXCM |
|---|---|---|
| Price | $232.52 | $66.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 34 | 21 |
| Target Price | ★ $323.73 | $86.86 |
| AVG Volume (30 Days) | 2.5M | ★ 5.1M |
| Earning Date | 11-25-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | N/A | ★ 1.80 |
| Revenue | $2,833,272,000.00 | ★ $4,515,900,000.00 |
| Revenue This Year | $26.93 | $17.41 |
| Revenue Next Year | $19.33 | $12.78 |
| P/E Ratio | ★ N/A | $36.68 |
| Revenue Growth | ★ 23.24 | 14.21 |
| 52 Week Low | $164.78 | $54.11 |
| 52 Week High | $336.99 | $93.25 |
| Indicator | ZS | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 31.48 | 56.28 |
| Support Level | $226.24 | $65.56 |
| Resistance Level | $234.82 | $68.19 |
| Average True Range (ATR) | 5.73 | 1.85 |
| MACD | 0.50 | 0.12 |
| Stochastic Oscillator | 29.62 | 38.99 |
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.